These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10429472)

  • 1. [Cancer and thromboembolism].
    Hara N; Kotho H; Kuwano K
    Nihon Rinsho; 1999 Jul; 57(7):1648-52. PubMed ID: 10429472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of venous thromboembolism in cancer patients.
    Levine MN; Lee AY
    Semin Thromb Hemost; 1999; 25(2):245-9. PubMed ID: 10357092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer and thromboembolism: from biology to clinics.
    Castelli R; Porro F
    Minerva Med; 2006 Apr; 97(2):175-89. PubMed ID: 16760856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thromboembolism in patients with cancer. Part II. Current treatment strategies.
    Viale PH; Schwartz RN
    Clin J Oncol Nurs; 2004 Oct; 8(5):465-9. PubMed ID: 15515280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of venous thromboembolism in cancer patients.
    Kakkar AK; Williamson RC
    Semin Thromb Hemost; 1999; 25(2):239-43. PubMed ID: 10357091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of low-molecular-weight heparins as supportive care therapy in cancer-associated thrombosis.
    Cunningham RS
    Semin Oncol; 2006 Apr; 33(2 Suppl 4):S17-25; quiz S41-2. PubMed ID: 16638457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of venous thromboembolism in cancer patients.
    Petralia GA; Kakkar AK
    Semin Thromb Hemost; 2007 Oct; 33(7):707-11. PubMed ID: 18000799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of thromboembolism in patients with cancer.
    Viale PH
    Oncol Nurs Forum; 1999; 26(10):1625-32; quiz 1633-4. PubMed ID: 10573679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer, thrombosis and heparin-induced thrombocytopenia.
    Prandoni P; Falanga A; Piccioli A
    Thromb Res; 2007; 120 Suppl 2():S137-40. PubMed ID: 18023709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer, coagulation, and anticoagulation.
    Letai A; Kuter DJ
    Oncologist; 1999; 4(6):443-9. PubMed ID: 10631688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism.
    Lee AY; Rickles FR; Julian JA; Gent M; Baker RI; Bowden C; Kakkar AK; Prins M; Levine MN
    J Clin Oncol; 2005 Apr; 23(10):2123-9. PubMed ID: 15699480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboembolism in cancer. Changing trends.
    Naschitz JE; Yeshurun D; Lev LM
    Cancer; 1993 Feb; 71(4):1384-90. PubMed ID: 8435814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Blood coagulation changes and neoplastic pathology].
    Corsi MP; De Martinis M; Di Leonardo G; Loreto MF; Modesti M; Quaglino D
    Recenti Prog Med; 2000 Oct; 91(10):532-7. PubMed ID: 11072743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thromboembolism complications in tumor diseases: pathophysiology, risk factors and preventive approaches].
    Südhoff T; Schmiegel W; Karthaus M
    Wien Med Wochenschr; 2001; 151(3-4):94-8. PubMed ID: 11789425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of long-term low-molecular weight heparin for the treatment of venous thromboembolism in palliative care patients with advanced cancer: a case series of sixty two patients.
    Noble SI; Hood K; Finlay IG
    Palliat Med; 2007 Sep; 21(6):473-6. PubMed ID: 17846086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High affinity binding of heparin by necrotic tumour cells neutralises anticoagulant activity--implications for cancer related thromboembolism and heparin therapy.
    Morita S; Gebska MA; Kakkar AK; Scully MF
    Thromb Haemost; 2001 Aug; 86(2):616-22. PubMed ID: 11522012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer and venous thromboembolism: an overview.
    Prandoni P; Piccioli A; Girolami A
    Haematologica; 1999 May; 84(5):437-45. PubMed ID: 10329923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombosis and cancer.
    Valente M; Ponte E
    Minerva Cardioangiol; 2000; 48(4-5):117-27. PubMed ID: 10959148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Warfarin versus low-molecular-weight heparin therapy in cancer patients.
    Zacharski LR; Prandoni P; Monreal M
    Oncologist; 2005 Jan; 10(1):72-9. PubMed ID: 15632254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulants and cancer survival.
    Piccioli A; Falanga A; Prandoni P
    Semin Thromb Hemost; 2006 Nov; 32(8):810-3. PubMed ID: 17171594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.